研究実績
2024.07.29
IFN-λ3 and CCL17 as predictors of disease progression in patients with mild to moderate COVID-19: A cohort study in a real-world setting.
Sekimoto Y, Sekiya M, Nojiri S, Hayakawa E, Masui Y, Tajima M, Nishino K, Nishizaki Y, Takahashi K. IFN-λ3 and CCL17 as predictors of disease progression in patients with mild to moderate COVID-19: A cohort study in a real-world setting.Respir Investig. 2023 Mar;61(2):153-156.
